Erhalte eine Antwort von diesem Arbeitgeber — ein Lebenslauf und ein Anschreiben, die genau auf das zugeschnitten sind, wonach gesucht wird.
Clario, part of Thermo Fisher Scientific, is seeking a Product Owner (f/m/d) to translate product strategy into actionable user stories and deliver value for patients and customers. You will collaborate with Product Management, Engineering and other stakeholders to clearly define requirements and prioritize the backlog.
You have a Bachelor’s degree or equivalent, at least 3 years in Agile environments, experience with backlog management, and strong communication.
Enhance your career at Clario, part of Thermo Fisher Scientific, as a Product Owner (f/m/d) and help transform product strategy into impactful technology solutions that accelerate the delivery of life-changing therapies. In this role, you will work closely with Product Management, Engineering, and other key stakeholders to ensure product requirements are clearly defined, prioritized, and delivered to create value for customers and patients.
At Clario, part of Thermo Fisher Scientific, our purpose is to transform lives by unlocking better evidence. It’s a cause that unites and inspires us. It’s why we come to work—and how we empower our people to make a positive impact every day. Whether you\'re advancing clinical science, building innovative technology, or supporting our global teams, your work helps bring life-changing therapies to patients faster.
Clario Privacy Policy Clario is a leading provider of endpoint data solutions to the clinical trials industry, generating high-quality clinical evidence for life sciences companies. We offer comprehensive evidence generation solutions that combine medical imaging, eCOA, precision motion, cardiac solutions and respiratory endpoints. For more than 50 years, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported over 30,000 clinical trials in more than 100 countries. Our global team of science, technology, and operational experts have supported over 70% of all FDA drug approvals since 2015.